Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
48
EXAS Quote, Financials, Valuation and Earnings
Last price:
$103.30
Seasonality move
:
3.51%
Day range:
$103.26 - $103.42
52-week range:
$38.81 - $103.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.01x
P/B ratio:
8.18x
Volume:
2.3M
Avg. volume:
2.4M
1-year change:
108.26%
Market cap:
$19.6B
Revenue:
$3.2B
EPS (TTM):
-$1.10
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
EXAS
EXACT Sciences Corp.
|
$860.8M | $0.08 | 17.92% | -84.17% | $105.81 |
|
DGX
Quest Diagnostics, Inc.
|
$2.8B | $2.36 | 6.52% | 21.66% | $217.38 |
|
GH
Guardant Health, Inc.
|
$272.3M | -$0.47 | 35.29% | -43.18% | $125.00 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.23 | 3.09% | 28.49% | $135.84 |
|
MTD
Mettler-Toledo International, Inc.
|
$1.1B | $12.81 | 6.27% | 11.39% | $1,501.38 |
|
NTRA
Natera, Inc.
|
$600.7M | -$0.53 | 22.18% | -19.94% | $257.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
EXAS
EXACT Sciences Corp.
|
$103.36 | $105.81 | $19.6B | -- | $0.00 | 0% | 6.01x |
|
DGX
Quest Diagnostics, Inc.
|
$204.39 | $217.38 | $22.5B | 23.35x | $0.80 | 1.57% | 2.09x |
|
GH
Guardant Health, Inc.
|
$107.42 | $125.00 | $14B | -- | $0.00 | 0% | 14.77x |
|
ILMN
Illumina, Inc.
|
$120.09 | $135.84 | $18.4B | 21.98x | $0.00 | 0% | 4.32x |
|
MTD
Mettler-Toledo International, Inc.
|
$1,375.57 | $1,501.38 | $28B | 32.66x | $0.00 | 0% | 7.06x |
|
NTRA
Natera, Inc.
|
$215.53 | $257.20 | $30.1B | -- | $0.00 | 0% | 13.74x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
EXAS
EXACT Sciences Corp.
|
51.36% | 1.552 | 13.14% | 1.97x |
|
DGX
Quest Diagnostics, Inc.
|
47.09% | -0.045 | 33.16% | 0.80x |
|
GH
Guardant Health, Inc.
|
136.47% | 0.817 | 16.98% | 2.94x |
|
ILMN
Illumina, Inc.
|
48.39% | 2.522 | 12.72% | 1.59x |
|
MTD
Mettler-Toledo International, Inc.
|
101.05% | 1.338 | 7.98% | 0.72x |
|
NTRA
Natera, Inc.
|
13.7% | 1.174 | 0.9% | 3.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
EXAS
EXACT Sciences Corp.
|
$615.8M | -$76.7M | -4.14% | -8.54% | -8.73% | $120.4M |
|
DGX
Quest Diagnostics, Inc.
|
$914M | $391M | 7.6% | 14.49% | 13.93% | $307M |
|
GH
Guardant Health, Inc.
|
$171.6M | -$99M | -36.05% | -8518.58% | -37.33% | -$45.8M |
|
ILMN
Illumina, Inc.
|
$778M | $257M | 16.96% | 35.12% | 22.16% | $263M |
|
MTD
Mettler-Toledo International, Inc.
|
$655.8M | $343.3M | 43.36% | -- | 30.39% | $184.1M |
|
NTRA
Natera, Inc.
|
$384.4M | -$97.6M | -21.88% | -26.6% | -16.48% | $24.5M |
EXACT Sciences Corp. vs. Competitors
-
Which has Higher Returns EXAS or DGX?
Quest Diagnostics, Inc. has a net margin of -9.79% compared to EXACT Sciences Corp.'s net margin of 9.12%. EXACT Sciences Corp.'s return on equity of -8.54% beat Quest Diagnostics, Inc.'s return on equity of 14.49%.
Company Gross Margin Earnings Per Share Invested Capital EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B DGXQuest Diagnostics, Inc.32.57% $2.18 $13.7B -
What do Analysts Say About EXAS or DGX?
EXACT Sciences Corp. has a consensus price target of $105.81, signalling upside risk potential of 2.37%. On the other hand Quest Diagnostics, Inc. has an analysts' consensus of $217.38 which suggests that it could grow by 6.35%. Given that Quest Diagnostics, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Quest Diagnostics, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings EXASEXACT Sciences Corp.1 20 0 DGXQuest Diagnostics, Inc.7 7 0 -
Is EXAS or DGX More Risky?
EXACT Sciences Corp. has a beta of 1.416, which suggesting that the stock is 41.594% more volatile than S&P 500. In comparison Quest Diagnostics, Inc. has a beta of 0.662, suggesting its less volatile than the S&P 500 by 33.785%.
-
Which is a Better Dividend Stock EXAS or DGX?
EXACT Sciences Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics, Inc. offers a yield of 1.57% to investors and pays a quarterly dividend of $0.80 per share. EXACT Sciences Corp. pays -- of its earnings as a dividend. Quest Diagnostics, Inc. pays out 36.57% of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios EXAS or DGX?
EXACT Sciences Corp. quarterly revenues are $878.4M, which are smaller than Quest Diagnostics, Inc. quarterly revenues of $2.8B. EXACT Sciences Corp.'s net income of -$86M is lower than Quest Diagnostics, Inc.'s net income of $256M. Notably, EXACT Sciences Corp.'s price-to-earnings ratio is -- while Quest Diagnostics, Inc.'s PE ratio is 23.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EXACT Sciences Corp. is 6.01x versus 2.09x for Quest Diagnostics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M DGXQuest Diagnostics, Inc.2.09x 23.35x $2.8B $256M
-
Which has Higher Returns EXAS or GH?
Guardant Health, Inc. has a net margin of -9.79% compared to EXACT Sciences Corp.'s net margin of -34.97%. EXACT Sciences Corp.'s return on equity of -8.54% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B GHGuardant Health, Inc.64.71% -$0.74 $971.9M -
What do Analysts Say About EXAS or GH?
EXACT Sciences Corp. has a consensus price target of $105.81, signalling upside risk potential of 2.37%. On the other hand Guardant Health, Inc. has an analysts' consensus of $125.00 which suggests that it could grow by 16.37%. Given that Guardant Health, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Guardant Health, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings EXASEXACT Sciences Corp.1 20 0 GHGuardant Health, Inc.17 1 1 -
Is EXAS or GH More Risky?
EXACT Sciences Corp. has a beta of 1.416, which suggesting that the stock is 41.594% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.631, suggesting its more volatile than the S&P 500 by 63.129%.
-
Which is a Better Dividend Stock EXAS or GH?
EXACT Sciences Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EXACT Sciences Corp. pays -- of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EXAS or GH?
EXACT Sciences Corp. quarterly revenues are $878.4M, which are larger than Guardant Health, Inc. quarterly revenues of $265.2M. EXACT Sciences Corp.'s net income of -$86M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, EXACT Sciences Corp.'s price-to-earnings ratio is -- while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EXACT Sciences Corp. is 6.01x versus 14.77x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M GHGuardant Health, Inc.14.77x -- $265.2M -$92.7M
-
Which has Higher Returns EXAS or ILMN?
Illumina, Inc. has a net margin of -9.79% compared to EXACT Sciences Corp.'s net margin of 28.79%. EXACT Sciences Corp.'s return on equity of -8.54% beat Illumina, Inc.'s return on equity of 35.12%.
Company Gross Margin Earnings Per Share Invested Capital EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B ILMNIllumina, Inc.67.07% $2.17 $5.3B -
What do Analysts Say About EXAS or ILMN?
EXACT Sciences Corp. has a consensus price target of $105.81, signalling upside risk potential of 2.37%. On the other hand Illumina, Inc. has an analysts' consensus of $135.84 which suggests that it could grow by 13.12%. Given that Illumina, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Illumina, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings EXASEXACT Sciences Corp.1 20 0 ILMNIllumina, Inc.8 8 1 -
Is EXAS or ILMN More Risky?
EXACT Sciences Corp. has a beta of 1.416, which suggesting that the stock is 41.594% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.450, suggesting its more volatile than the S&P 500 by 44.964%.
-
Which is a Better Dividend Stock EXAS or ILMN?
EXACT Sciences Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EXACT Sciences Corp. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EXAS or ILMN?
EXACT Sciences Corp. quarterly revenues are $878.4M, which are smaller than Illumina, Inc. quarterly revenues of $1.2B. EXACT Sciences Corp.'s net income of -$86M is lower than Illumina, Inc.'s net income of $334M. Notably, EXACT Sciences Corp.'s price-to-earnings ratio is -- while Illumina, Inc.'s PE ratio is 21.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EXACT Sciences Corp. is 6.01x versus 4.32x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M ILMNIllumina, Inc.4.32x 21.98x $1.2B $334M
-
Which has Higher Returns EXAS or MTD?
Mettler-Toledo International, Inc. has a net margin of -9.79% compared to EXACT Sciences Corp.'s net margin of 25.3%. EXACT Sciences Corp.'s return on equity of -8.54% beat Mettler-Toledo International, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B MTDMettler-Toledo International, Inc.58.05% $13.98 $2.2B -
What do Analysts Say About EXAS or MTD?
EXACT Sciences Corp. has a consensus price target of $105.81, signalling upside risk potential of 2.37%. On the other hand Mettler-Toledo International, Inc. has an analysts' consensus of $1,501.38 which suggests that it could grow by 9.15%. Given that Mettler-Toledo International, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Mettler-Toledo International, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings EXASEXACT Sciences Corp.1 20 0 MTDMettler-Toledo International, Inc.5 8 0 -
Is EXAS or MTD More Risky?
EXACT Sciences Corp. has a beta of 1.416, which suggesting that the stock is 41.594% more volatile than S&P 500. In comparison Mettler-Toledo International, Inc. has a beta of 1.424, suggesting its more volatile than the S&P 500 by 42.389%.
-
Which is a Better Dividend Stock EXAS or MTD?
EXACT Sciences Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mettler-Toledo International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EXACT Sciences Corp. pays -- of its earnings as a dividend. Mettler-Toledo International, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EXAS or MTD?
EXACT Sciences Corp. quarterly revenues are $878.4M, which are smaller than Mettler-Toledo International, Inc. quarterly revenues of $1.1B. EXACT Sciences Corp.'s net income of -$86M is lower than Mettler-Toledo International, Inc.'s net income of $285.8M. Notably, EXACT Sciences Corp.'s price-to-earnings ratio is -- while Mettler-Toledo International, Inc.'s PE ratio is 32.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EXACT Sciences Corp. is 6.01x versus 7.06x for Mettler-Toledo International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M MTDMettler-Toledo International, Inc.7.06x 32.66x $1.1B $285.8M
-
Which has Higher Returns EXAS or NTRA?
Natera, Inc. has a net margin of -9.79% compared to EXACT Sciences Corp.'s net margin of -14.78%. EXACT Sciences Corp.'s return on equity of -8.54% beat Natera, Inc.'s return on equity of -26.6%.
Company Gross Margin Earnings Per Share Invested Capital EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B NTRANatera, Inc.64.91% -$0.64 $1.5B -
What do Analysts Say About EXAS or NTRA?
EXACT Sciences Corp. has a consensus price target of $105.81, signalling upside risk potential of 2.37%. On the other hand Natera, Inc. has an analysts' consensus of $257.20 which suggests that it could grow by 19.33%. Given that Natera, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Natera, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings EXASEXACT Sciences Corp.1 20 0 NTRANatera, Inc.13 2 0 -
Is EXAS or NTRA More Risky?
EXACT Sciences Corp. has a beta of 1.416, which suggesting that the stock is 41.594% more volatile than S&P 500. In comparison Natera, Inc. has a beta of 1.636, suggesting its more volatile than the S&P 500 by 63.611%.
-
Which is a Better Dividend Stock EXAS or NTRA?
EXACT Sciences Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EXACT Sciences Corp. pays -- of its earnings as a dividend. Natera, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EXAS or NTRA?
EXACT Sciences Corp. quarterly revenues are $878.4M, which are larger than Natera, Inc. quarterly revenues of $592.2M. EXACT Sciences Corp.'s net income of -$86M is higher than Natera, Inc.'s net income of -$87.5M. Notably, EXACT Sciences Corp.'s price-to-earnings ratio is -- while Natera, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EXACT Sciences Corp. is 6.01x versus 13.74x for Natera, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M NTRANatera, Inc.13.74x -- $592.2M -$87.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
73
HYMC alert for Feb 19
Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.
Buy
57
GLBE alert for Feb 19
Global-e Online Ltd. [GLBE] is up 4.19% over the past day.
Sell
37
ACLS alert for Feb 19
Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.
